| Drug Type Small molecule drug | 
| Synonyms | 
| Action inhibitors | 
| Mechanism COX-2 inhibitors(Cyclooxygenase-2 inhibitors), IL-1β inhibitors(Interleukin-1 beta inhibitors), IL-6 inhibitors(Interleukin-6 inhibitors) + [2] | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Neuroinflammation | Preclinical | Canada  | 06 May 2024 | 





